Invesco Pharmaceuticals ETF
PJP
71 hedge funds and large institutions have $240M invested in Invesco Pharmaceuticals ETF in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 20 reducing their positions, and 9 closing their positions.
45% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 20
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
32% more capital invested
Capital invested by funds: $181M → $240M (+$58.2M)
3% more funds holding
Funds holding: 69 → 71 (+2)
0.73% less ownership
Funds ownership: 26.42% → 25.68% (-0.73%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.6M |
| 2 |
SCM
Summit Capital Management
Seattle,
Washington
|
+$6.44M |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$3.92M |
| 4 |
FAAS
First Allied Advisory Services
San Diego,
California
|
+$3.43M |
| 5 |
Morgan Stanley
New York
|
+$2.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFG
Pacific Financial Group
Bellevue,
Washington
|
-$4.49M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
-$3.49M |
| 3 |
WCM
Weatherstone Capital Management
Denver,
Colorado
|
-$2.87M |
| 4 |
AssetMark Inc
Concord,
California
|
-$1.53M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.39M |
PJP Hedge Fund Activity: Q4 2013 in Review
71 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q4 2013, worth a combined $240M — up 32% from $181M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new PJP positions and 9 closed out — a net gain of 4 holders — while 29 added to existing stakes and 20 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $14.6M. The largest seller was Pacific Financial Group, cutting an estimated $4.49M.
- 71 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q4 2013, up from 69 in Q3 2013.
- Funds reported $240M of Invesco Pharmaceuticals ETF stock for Q4 2013, up 32% quarter-over-quarter.
- 13 funds opened new Invesco Pharmaceuticals ETF positions in Q4 2013 and 9 closed out, a net change of +4 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q4 2013 was Fidelity Investments, an estimated $14.6M added.
- The largest Invesco Pharmaceuticals ETF seller in Q4 2013 was Pacific Financial Group, an estimated $4.49M sold.
Based on aggregated 13F filings for Q4 2013.